LAURA MOGEL: Open Payments
NPI 1043975527 · NORTH CHESTERFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 40 payments from 18 companies in 2025. Trend: 2023 $729 · 2024 $687 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $189 |
| Eisai Inc. | 2 | $136 |
| Novartis Pharmaceuticals Corporation | 5 | $93 |
| Biogen, Inc. | 4 | $84 |
| Alexion Pharmaceuticals, Inc. | 2 | $61 |
| TG Therapeutics, Inc. | 2 | $59 |
| Lilly USA, LLC | 2 | $45 |
| SK Life Science, Inc. | 2 | $44 |
| Genentech USA, Inc. | 1 | $31 |
| Ultragenyx Pharmaceutical Inc. | 1 | $29 |
Products named: Leqembi, QULIPTA, KESIMPTA, ULTOMIRIS, BRIUMVI, TYSABRI, UBRELVY, BOTOX.
Industry payments across VA — which companies pay providers there.
